General University Hospital, Prague
Clinical trials sponsored by General University Hospital, Prague, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could losing weight on 800 calories a day reshape your bone marrow? Results expected Nov 2026 (estimated)
- Can a liver drug also protect the heart? study tests ursodeoxycholic acid in fatty liver disease Results expected Nov 2026 (estimated)
- New scan could reveal hidden cancer in High-Risk prostate patients Results expected Dec 2026 (estimated)
- Can talk therapy and mindfulness shrink a fatty liver? Results expected Dec 2026 (estimated)
-
Can a liver drug also protect the heart? study tests ursodeoxycholic acid in fatty liver disease
Disease control OngoingResearchers at a Prague hospital are observing whether ursodeoxycholic acid, a drug used for certain liver conditions, affects liver fat, liver enzymes, and markers of heart and blood vessel health in people with non-alcoholic fatty liver disease. The study includes 20 adults who…
Sponsor: General University Hospital, Prague • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New scan could reveal hidden cancer in High-Risk prostate patients
Knowledge-focused OngoingThis study involves 400 men with high-risk prostate cancer who have not yet received treatment. Researchers are using a special type of scan called PSMA PET to see if it can find cancer that has spread to lymph nodes or other parts of the body, which standard scans often miss. Th…
Sponsor: General University Hospital, Prague • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC